| Literature DB >> 12126895 |
Yoshitsugu Kojima1, Ke-Qin Xin, Takaaki Ooki, Kenji Hamajima, Tomohiro Oikawa, Kaori Shinoda, Tomomi Ozaki, Yuka Hoshino, Nao Jounai, Masatoshi Nakazawa, Dennis Klinman, Kenji Okuda.
Abstract
Synthetic oligodeoxynucleotides (ODN) containing unmethylated CpG motifs trigger an immune response characterized by the activation of B cells, NK cells and monocytes/macrophages. Based on evidence that the immunogenicity of DNA vaccines can be augmented by the addition of CpG motifs, 5-20 additional CpG motifs were cloned into a pUC-derived plasmid. Treating bone-marrow derived dendritic cells (BM-DCs) with CpG-enriched plasmids in vitro boosted their expressions of MHC class II molecules, the CD40 and CD86 activation markers. Co-administering the CpG-enriched plasmids with a DNA vaccine encoding the envelope glycoprotein of HIV to BALB/c mice significantly increased HIV-specific cell mediated and humoral immunity. A significant boost was observed when the CpG plasmid was administered either 2 or 4 days after DNA vaccination. Plasmids containing 20 CpG copies were the most effective immune enhancers both in vitro and in vivo. These results suggest that plasmids containing multiple CpG motifs may improve the immunogenicity of DNA vaccines.Entities:
Mesh:
Substances:
Year: 2002 PMID: 12126895 DOI: 10.1016/s0264-410x(02)00238-4
Source DB: PubMed Journal: Vaccine ISSN: 0264-410X Impact factor: 3.641